Document Detail


Notoriety to respectability: a short history of arsenic prior to its present day use in haematology.
MedLine Citation:
PMID:  19298591     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper looks at arsenic, and in particular the trioxide, from the days of the ancient Chinese, Egyptians, Greeks and Romans, through the 17th-20th centuries to its adoption by today's haematologists. It looks at its commercial and medical uses, past and present, its notoriety as a poison, it's reputation as a 'tonic' and therapeutic agent, many of the famous people associated with it including Thomas Fowler, William Withering and Robert Christison, and the promise an 18th century panacea now offers 21st century patients under the care of today's haematologists and tomorrow's oncologists.
Authors:
Derek Doyle
Publication Detail:
Type:  Historical Article; Journal Article; Portraits     Date:  2009-03-02
Journal Detail:
Title:  British journal of haematology     Volume:  145     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-30     Completed Date:  2009-06-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  309-17     Citation Subset:  IM    
Affiliation:
derekdoyle@waitrose.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arsenic / history*
Hematology / history
History, 15th Century
History, 16th Century
History, 17th Century
History, 18th Century
History, 19th Century
History, 20th Century
History, 21st Century
History, Ancient
History, Medieval
Humans
Chemical
Reg. No./Substance:
7440-38-2/Arsenic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute...
Next Document:  The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in p...